Cystic fibrosis: The miracle drugs priced out of reach
Regulators around the world have questioned the high price set by Vertex Pharmaceuticals.
Similar Posts
Watch: Boy’s tearful thanks after leukaemia all-clear
A 13-year-old boy who has raised thousands for charity after being diagnosed with leukaemia has shared his delight at being given the all clear. In a tearful video, Hughie thanked his best friend Freddie, who played a big part in his fundraising. Watch as they tell BBC Breakfast about the moment they got the good…
Fight cold and flu with these 10 immune-boosting recipes from a Texas registered dietitian
With flu season in full swing — and other seasonal respiratory infections also spiking across the U.S. — experts say it’s important to keep your immune system strong and healthy during this time of year. One way to combat seasonal illness is to regularly consume key nutrients and proteins that help improve immune health, according…
FDA gives Florida green light to import drugs in bulk from Canada
For the first time, the U.S. Food and Drug Administration has authorized a Florida program to import certain prescription drugs in bulk from Canada. The approval paves the way for other states to request permission to import medications from Canada, where drug prices are much cheaper, to significantly cut costs for American consumers. Floria’s proposal…
Vertex shares pop after nonopioid painkiller posts positive midstage trial results
A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston on Oct. 23, 2019. Brian Snyder | Reuters Shares of Vertex Pharmaceuticals jumped Wednesday after the company’s painkiller, which is being tested as an alternative to opioids, significantly decreased pain in a midstage trial. Those positive results for diabetes patients suffering…
At-home health test maker Thorne explores sale | Reuters News Agency
Business & FinanceDealsHealth 21 July 2023, 6:41 pm 1 minute Reuters exclusively reported that Thorne HealthTech Inc (THRN.O), a provider of at-home health tests and nutritional supplements, is exploring a sale. Market Impact Thorne’s shares ended trading on Friday up 12.9% at $5.95 on the news, giving the company a market value of $320 million….
Toxic debate over lab leak theory hampers search for Covid origins
US agencies cannot agree on how the pandemic started, with the scientific community bitterly divided.
